148 related articles for article (PubMed ID: 22495115)
1. Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies.
Plieskatt JL; Rezende WC; Olsen CM; Trefethen JM; Joshi SB; Middaugh CR; Hotez PJ; Bottazzi ME
Hum Vaccin Immunother; 2012 Jun; 8(6):765-76. PubMed ID: 22495115
[TBL] [Abstract][Full Text] [Related]
2. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
Curti E; Seid CA; Hudspeth E; Center L; Rezende W; Pollet J; Kwityn C; Hammond M; Matsunami RK; Engler DA; Hotez PJ; Elena Bottazzi M
Hum Vaccin Immunother; 2014; 10(7):1914-25. PubMed ID: 25424799
[TBL] [Abstract][Full Text] [Related]
3. Potency testing for the experimental Na-GST-1 hookworm vaccine.
Jariwala AR; Oliveira LM; Diemert DJ; Keegan B; Plieskatt JL; Periago MV; Bottazzi ME; Hotez PJ; Bethony JM
Expert Rev Vaccines; 2010 Oct; 9(10):1219-30. PubMed ID: 20923271
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen.
Goud GN; Deumic V; Gupta R; Brelsford J; Zhan B; Gillespie P; Plieskatt JL; Tsao EI; Hotez PJ; Bottazzi ME
Protein Expr Purif; 2012 Jun; 83(2):145-51. PubMed ID: 22503665
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus.
Xiao S; Zhan B; Xue J; Goud GN; Loukas A; Liu Y; Williamson A; Liu S; Deumic V; Hotez P
Exp Parasitol; 2008 Jan; 118(1):32-40. PubMed ID: 17645877
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.
Zhan B; Perally S; Brophy PM; Xue J; Goud G; Liu S; Deumic V; de Oliveira LM; Bethony J; Bottazzi ME; Jiang D; Gillespie P; Xiao SH; Gupta R; Loukas A; Ranjit N; Lustigman S; Oksov Y; Hotez P
Infect Immun; 2010 Apr; 78(4):1552-63. PubMed ID: 20145100
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
Seid CA; Curti E; Jones RM; Hudspeth E; Rezende W; Pollet J; Center L; Versteeg L; Pritchard S; Musiychuk K; Yusibov V; Hotez PJ; Bottazzi ME
Hum Vaccin Immunother; 2015; 11(6):1474-88. PubMed ID: 25905574
[TBL] [Abstract][Full Text] [Related]
9. Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats.
Mendez S; D' Samuel A; Antoine AD; Ahn S; Hotez P
Parasite Immunol; 2008 Jan; 30(1):53-6. PubMed ID: 18086017
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials.
Goud GN; Bottazzi ME; Zhan B; Mendez S; Deumic V; Plieskatt J; Liu S; Wang Y; Bueno L; Fujiwara R; Samuel A; Ahn SY; Solanki M; Asojo OA; Wang J; Bethony JM; Loukas A; Roy M; Hotez PJ
Vaccine; 2005 Sep; 23(39):4754-64. PubMed ID: 16054275
[TBL] [Abstract][Full Text] [Related]
11. Probing of a human proteome microarray with a recombinant pathogen protein reveals a novel mechanism by which hookworms suppress B-cell receptor signaling.
Tribolet L; Cantacessi C; Pickering DA; Navarro S; Doolan DL; Trieu A; Fei H; Chao Y; Hofmann A; Gasser RB; Giacomin PR; Loukas A
J Infect Dis; 2015 Feb; 211(3):416-25. PubMed ID: 25139017
[TBL] [Abstract][Full Text] [Related]
12. Experimental approaches to the development of a recombinant hookworm vaccine.
Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
[TBL] [Abstract][Full Text] [Related]
13. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
Diemert DJ; Pinto AG; Freire J; Jariwala A; Santiago H; Hamilton RG; Periago MV; Loukas A; Tribolet L; Mulvenna J; Correa-Oliveira R; Hotez PJ; Bethony JM
J Allergy Clin Immunol; 2012 Jul; 130(1):169-76.e6. PubMed ID: 22633322
[TBL] [Abstract][Full Text] [Related]
14. Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.
Zhan B; Santiago H; Keegan B; Gillespie P; Xue J; Bethony J; de Oliveira LM; Jiang D; Diemert D; Xiao SH; Jones K; Feng X; Hotez PJ; Bottazzi ME
Parasite Immunol; 2012; 34(8-9):404-11. PubMed ID: 22651670
[TBL] [Abstract][Full Text] [Related]
15. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection.
Asojo OA; Goud G; Dhar K; Loukas A; Zhan B; Deumic V; Liu S; Borgstahl GE; Hotez PJ
J Mol Biol; 2005 Feb; 346(3):801-14. PubMed ID: 15713464
[TBL] [Abstract][Full Text] [Related]
16. Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine.
Brelsford JB; Plieskatt JL; Yakovleva A; Jariwala A; Keegan BP; Peng J; Xia P; Li G; Campbell D; Periago MV; Correa-Oliveira R; Bottazzi ME; Hotez PJ; Diemert D; Bethony JM
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005385. PubMed ID: 28192438
[TBL] [Abstract][Full Text] [Related]
17. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults.
Bethony JM; Simon G; Diemert DJ; Parenti D; Desrosiers A; Schuck S; Fujiwara R; Santiago H; Hotez PJ
Vaccine; 2008 May; 26(19):2408-17. PubMed ID: 18396361
[TBL] [Abstract][Full Text] [Related]
18. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.
Mouwenda YD; Betouke Ongwe ME; Sonnet F; Stam KA; Labuda LA; De Vries S; Grobusch MP; Zinsou FJ; Honkpehedji YJ; Dejon Agobe JC; Diemert DJ; van Leeuwen R; Bottazzi ME; Hotez PJ; Kremsner PG; Bethony JM; Jochems SP; Adegnika AA; Massinga Loembe M; Yazdanbakhsh M
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009732. PubMed ID: 34597297
[TBL] [Abstract][Full Text] [Related]
19. The Human Hookworm Vaccine.
Hotez PJ; Diemert D; Bacon KM; Beaumier C; Bethony JM; Bottazzi ME; Brooker S; Couto AR; Freire Mda S; Homma A; Lee BY; Loukas A; Loblack M; Morel CM; Oliveira RC; Russell PK
Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B227-32. PubMed ID: 23598487
[TBL] [Abstract][Full Text] [Related]
20. Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis.
Cheng W; Curti E; Rezende WC; Kwityn C; Zhan B; Gillespie P; Plieskatt J; Joshi SB; Volkin DB; Hotez PJ; Middaugh CR; Bottazzi ME
Hum Vaccin Immunother; 2013 Nov; 9(11):2351-61. PubMed ID: 23880663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
